Clinical Trial Update: Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at Mahidol University is evaluating mesenchymal stem cells combined with cooling therapy for neonatal hypoxic-ischemic encephalopathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Brain Injury
• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Mesenchymal stem cells with cooling therapy (Mesenchymal stem cells with cooling therapy)

Snippet

Sponsor: Mahidol University | Conditions: Hypoxic-Ischemic Encephalopathy, Neonatal, Brain Injuries, Hypoxic-Ischemic | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING